ClinicalTrials.govpublic full text
Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms
myeloproliferative neoplasm, efficacy and safety profile, direct oral anticoagulants, real world data, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876258
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.